WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005115351) HORMONAL CONTRACEPTIVE CONTAINING A COMBINATION OF ETHINYL ESTRADIOL AND CHLORMADINONE ACETATE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/115351    International Application No.:    PCT/EP2005/005763
Publication Date: 08.12.2005 International Filing Date: 27.05.2005
Chapter 2 Demand Filed:    04.02.2006    
IPC:
A61K 9/36 (2006.01), A61K 31/565 (2006.01), A61K 31/57 (2006.01)
Applicants: GRÜNENTHAL GMBH [DE/DE]; Zieglerstr. 6, 52078 Aachen (DE) (For All Designated States Except US).
KLOSE, Janine [DE/DE]; (DE) (For US Only).
BARTHOLOMÄUS, Johannes [DE/DE]; (DE) (For US Only).
WILSMANN, Klaus-Michael [DE/DE]; (DE) (For US Only).
SCHRAMM, Georg [DE/DE]; (DE) (For US Only)
Inventors: KLOSE, Janine; (DE).
BARTHOLOMÄUS, Johannes; (DE).
WILSMANN, Klaus-Michael; (DE).
SCHRAMM, Georg; (DE)
Agent: BROSCH, Oliver; Kutzenberger & Wolff, Theodor-Heuss-Ring 23, 50668 Köln (DE)
Priority Data:
10 2004 026 670.0 28.05.2004 DE
Title (DE) HORMONALES KONTRAZEPTIVUM ENTHALTEND EINE KOMBINATION AUS ETHINYLESTRADIOL UND CHLORMADINONACETAT
(EN) HORMONAL CONTRACEPTIVE CONTAINING A COMBINATION OF ETHINYL ESTRADIOL AND CHLORMADINONE ACETATE
(FR) CONTRACEPTIF HORMONAL CONTENANT UNE ASSOCIATION D'ETHINYLESTRADIOL ET D'ACETATE DE CHLORMADINONE
Abstract: front page image
(DE)Die vorliegende Erfindung betrifft ein hormonales Kontrazeptivum aus 21 bis 25 hormonhaltigen Tages-Einheiten, die eine Kombination aus Ethinylestradiol in einer Menge < 25 µg und Chlormadinonacetat in einer Menge von < 5 mg enthalten, und aus gegebenenfalls 7 bis 3 hormonfreien Tages-Einheiten zur oralen Verabreichung an Frauen.
(EN)The invention relates to a hormonal contraceptive composed of 21 to 25 hormone-containing daily doses which comprise a combination of ethinyl estradiol at a quantity of < 25 µg, chlormadinone acetate at a quantity of < 5 mg, and 7 to 3 optional hormone-free daily doses for oral administration to women.
(FR)L'invention concerne un contraceptif hormonal comprenant entre 21 et 25 doses journalières contenant des hormones, à savoir une association d'éthinylestradiol et d'acétate de chlormadinone, respectivement dans des quantités strictement inférieures à 25 $g(m)g et 5 mg, et éventuellement entre 7 et 3 doses journalières exemptes d'hormone. Le contraceptif hormonal selon l'invention est destiné à être administré à des femmes par voie orale.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: German (DE)
Filing Language: German (DE)